Regional Scientific Director, Central
Amylyx Pharmaceuticals(14 days ago)
About this role
A Regional Scientific Director at Amylyx is a field-based medical affairs professional supporting the company’s clinical-stage programs in PBH, Wolfram syndrome, and ALS. The role connects external medical and academic communities with the company to inform Medical Affairs strategy and ensure timely, accurate dissemination of scientific information. It is part of a mission-driven team focused on advancing treatments for diseases with high unmet needs.
Required Skills
- Presentation
- Communication
- Project Management
- Data Analysis
- Scientific Communication
- Relationship Building
- Clinical Research
- Medical Education
- Literature Review
- Regulatory Compliance
Qualifications
- Advanced Degree (PhD, PharmD, DNP, DHSc, MD)
- Valid Driver's License
About Amylyx Pharmaceuticals
amylyx.comAmylyx is a biopharmaceutical company focused on developing treatments for progressive neurodegenerative diseases. Its lead therapy, AMX0035 (marketed as Relyvrio), is a combination treatment for ALS designed to protect neurons by targeting mitochondrial and endoplasmic reticulum dysfunction. Amylyx advances a pipeline testing similar neuroprotective approaches in other neurological disorders and runs clinical trials to generate patient-centered evidence. The company emphasizes translational research, regulatory engagement, and partnerships with patients and clinicians to bring new therapies to market.
Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Amylyx Pharmaceuticals
Similar Jobs
Senior Manager, Scientific Communications
Heartflow(25 days ago)
Senior Director, Medical Affairs Publications
Mind Medicine(22 days ago)
Director, Scientific Affairs (Oncology)
The Lockwood Group, LLC(13 days ago)
Director, Scientific Communications
Nuvalent, Inc.(11 days ago)
Senior Scientific Associate
Ogilvy Canada(7 days ago)
Medical Science Liaison (MSL)
BridgeBio Pharma(7 hours ago)